2012 Q1 Form 10-Q Financial Statement
#000144530512001771 Filed on May 15, 2012
Income Statement
Concept | 2012 Q1 | 2011 Q4 | 2011 Q1 |
---|---|---|---|
Revenue | $70.68M | $65.53M | $70.89M |
YoY Change | -0.3% | -1.31% | 12.53% |
Cost Of Revenue | $28.30M | $28.20M | $27.40M |
YoY Change | 3.28% | 8.46% | 13.22% |
Gross Profit | $47.70M | $47.00M | $43.70M |
YoY Change | 9.15% | 16.63% | 12.63% |
Gross Profit Margin | 67.49% | 71.72% | 61.64% |
Selling, General & Admin | $5.200M | $4.400M | $6.000M |
YoY Change | -13.33% | 0.0% | 33.33% |
% of Gross Profit | 10.9% | 9.36% | 13.73% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $16.70M | $25.00M | $21.90M |
YoY Change | -23.74% | 22.55% | 16.49% |
% of Gross Profit | 35.01% | 53.19% | 50.11% |
Operating Expenses | $28.10M | $27.00M | $26.00M |
YoY Change | 8.08% | 14.89% | 18.18% |
Operating Profit | $10.45M | $11.73M | $11.91M |
YoY Change | -12.3% | -30.17% | -29.08% |
Interest Expense | -$18.10M | -$18.30M | -$22.10M |
YoY Change | -18.1% | 5.78% | 38.99% |
% of Operating Profit | -173.22% | -156.0% | -185.5% |
Other Income/Expense, Net | -$11.01M | -$9.724M | -$9.724M |
YoY Change | 13.18% | ||
Pretax Income | $1.400M | $1.700M | -$6.400M |
YoY Change | -121.88% | -525.0% | -1700.0% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | 0.0% | 0.0% | |
Net Earnings | -$315.0K | $1.995M | $2.150M |
YoY Change | -114.65% | 398.75% | -53.26% |
Net Earnings / Revenue | -0.45% | 3.04% | 3.03% |
Basic Earnings Per Share | $0.00 | $0.00 | $0.01 |
Diluted Earnings Per Share | $0.00 | $0.00 | $0.01 |
COMMON SHARES | |||
Basic Shares Outstanding | 228.9M shares | 227.8M shares | 214.8M shares |
Diluted Shares Outstanding | 228.9M shares | 228.3M shares | 215.0M shares |
Balance Sheet
Concept | 2012 Q1 | 2011 Q4 | 2011 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $6.600M | $4.700M | $3.000M |
YoY Change | 120.0% | -95.85% | -72.73% |
Cash & Equivalents | $35.12M | $69.49M | $207.4M |
Short-Term Investments | |||
Other Short-Term Assets | $44.90M | $45.10M | |
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | $6.500M | $7.600M | $15.00M |
Other Receivables | $32.30M | $30.40M | $0.00 |
Total Short-Term Assets | $90.30M | $87.80M | $3.000M |
YoY Change | 2910.0% | -22.51% | -72.73% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $2.252B | $2.272B | $2.092B |
YoY Change | 7.66% | 8.86% | 15.66% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $1.300M | $1.300M | |
YoY Change | |||
Other Assets | $26.80M | $42.40M | $16.70M |
YoY Change | 60.48% | 77.41% | 943.75% |
Total Long-Term Assets | $2.367B | $2.204B | $2.294B |
YoY Change | 3.21% | 2.1% | 19.36% |
TOTAL ASSETS | |||
Total Short-Term Assets | $90.30M | $87.80M | $3.000M |
Total Long-Term Assets | $2.367B | $2.204B | $2.294B |
Total Assets | $2.458B | $2.292B | $2.297B |
YoY Change | 7.01% | 0.87% | 18.83% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $47.00M | $72.20M | $55.80M |
YoY Change | -15.77% | 15.15% | -5.1% |
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $47.00M | $72.20M | $55.80M |
YoY Change | -15.77% | 15.15% | -5.1% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $1.419B | $1.394B | $1.293B |
YoY Change | 9.71% | -1.02% | 24.93% |
Other Long-Term Liabilities | $52.30M | $50.50M | $45.40M |
YoY Change | 15.2% | 14.51% | -1.52% |
Total Long-Term Liabilities | $1.471B | $1.444B | $1.339B |
YoY Change | 9.89% | -0.55% | 23.8% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $47.00M | $72.20M | $55.80M |
Total Long-Term Liabilities | $1.471B | $1.444B | $1.339B |
Total Liabilities | $918.1M | $720.5M | $1.394B |
YoY Change | -34.15% | -7.71% | 21.88% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$509.1M | -$467.2M | |
YoY Change | 50.63% | ||
Common Stock | $2.045B | $2.035B | |
YoY Change | 13.19% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $1.536B | $1.567B | $1.657B |
YoY Change | |||
Total Liabilities & Shareholders Equity | $2.458B | $2.292B | $2.297B |
YoY Change | 7.01% | 0.87% | 18.83% |
Cashflow Statement
Concept | 2012 Q1 | 2011 Q4 | 2011 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$315.0K | $1.995M | $2.150M |
YoY Change | -114.65% | 398.75% | -53.26% |
Depreciation, Depletion And Amortization | $16.70M | $25.00M | $21.90M |
YoY Change | -23.74% | 22.55% | 16.49% |
Cash From Operating Activities | $26.11M | $40.70M | $25.11M |
YoY Change | 3.96% | 116.49% | -11.27% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$44.50M | $31.40M | -$25.50M |
YoY Change | 74.51% | -123.91% | 0.79% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $33.80M | -$76.30M | -$45.00M |
YoY Change | -175.11% | 10.74% | -357.14% |
Cash From Investing Activities | -$220.8M | -$45.00M | -$28.47M |
YoY Change | 675.55% | -77.52% | 269.77% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $9.916M | -$202.3M | |
YoY Change | -104.9% | -1448.63% | |
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $160.3M | 5.100M | $181.5M |
YoY Change | -11.66% | -98.2% | -1278.55% |
NET CHANGE | |||
Cash From Operating Activities | $26.11M | 40.70M | $25.11M |
Cash From Investing Activities | -$220.8M | -45.00M | -$28.47M |
Cash From Financing Activities | $160.3M | 5.100M | $181.5M |
Net Change In Cash | -$34.37M | 800.0K | $178.1M |
YoY Change | -119.29% | -99.22% | 3325.67% |
FREE CASH FLOW | |||
Cash From Operating Activities | $26.11M | $40.70M | $25.11M |
Capital Expenditures | -$44.50M | $31.40M | -$25.50M |
Free Cash Flow | $70.61M | $9.300M | $50.61M |
YoY Change | 39.51% | -93.8% | -5.58% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2012Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Nonvested Shares Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonvestedSharesRequisiteServicePeriodRecognition
|
1002000 | USD |
CY2011Q1 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
15002000 | USD |
CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
69491000 | USD |
CY2011Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
47801000 | USD |
CY2010Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
29270000 | USD |
CY2011Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
207405000 | USD |
CY2012Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
43244000 | USD |
CY2011Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
178135000 | USD |
CY2011Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
2032305000 | USD |
CY2012Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
2042528000 | USD |
CY2012Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-34371000 | USD |
CY2011Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Nonvested Shares Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonvestedSharesRequisiteServicePeriodRecognition
|
897000 | USD |
CY2011Q4 | us-gaap |
Assets
Assets
|
2291629000 | USD |
CY2012Q1 | us-gaap |
Assets
Assets
|
2457596000 | USD |
CY2011Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
1062000 | USD |
CY2012Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
2321000 | USD |
CY2012Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
2578000 | USD |
CY2011Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
2789000 | USD |
CY2012Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
35120000 | USD |
CY2011Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2012Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2011Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2012Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2011Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2012Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
CY2012Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
229514049 | shares |
CY2011Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
228491312 | shares |
CY2012Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
229514049 | shares |
CY2011Q4 | us-gaap |
Liabilities
Liabilities
|
720504000 | USD |
CY2012Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
2457596000 | USD |
CY2011Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
228491312 | shares |
CY2011Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2284000 | USD |
CY2012Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
2295000 | USD |
CY2012Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
60544000 | USD |
CY2011Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
58978000 | USD |
CY2012Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
27357000 | USD |
CY2011Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
26750000 | USD |
CY2011Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
1792000 | USD |
CY2012Q1 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
2270000 | USD |
CY2011Q1 | us-gaap |
Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
|
23858000 | USD |
CY2012Q1 | us-gaap |
Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
|
22716000 | USD |
CY2011Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.01 | |
CY2012Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
CY2011Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.01 | |
CY2012Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
CY2012Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
296731000 | USD |
CY2011Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
272390000 | USD |
CY2012Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8150000 | USD |
CY2011Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
7308000 | USD |
CY2011Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
229000 | USD |
CY2012Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1045000 | USD |
CY2011Q1 | us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
-866000 | USD |
CY2012Q1 | us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
-84000 | USD |
CY2011Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-21000 | USD |
CY2012Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1956000 | USD |
CY2011Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
2872000 | USD |
CY2012Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
3265000 | USD |
CY2012Q1 | us-gaap |
Interest Paid
InterestPaid
|
9916000 | USD |
CY2011Q1 | us-gaap |
Interest Paid
InterestPaid
|
10984000 | USD |
CY2011Q1 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
118000 | USD |
CY2012Q1 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
27000 | USD |
CY2012Q1 | us-gaap |
Liabilities
Liabilities
|
918149000 | USD |
CY2011Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
2291629000 | USD |
CY2012Q1 | us-gaap |
Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
|
200000000 | USD |
CY2011Q4 | us-gaap |
Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
|
0 | USD |
CY2012Q1 | us-gaap |
Loans Assumed1
LoansAssumed1
|
0 | USD |
CY2011Q1 | us-gaap |
Loans Assumed1
LoansAssumed1
|
6657000 | USD |
CY2012Q1 | us-gaap |
Minority Interest In Net Income Loss Limited Partnerships
MinorityInterestInNetIncomeLossLimitedPartnerships
|
8000 | USD |
CY2011Q1 | us-gaap |
Minority Interest In Net Income Loss Limited Partnerships
MinorityInterestInNetIncomeLossLimitedPartnerships
|
40000 | USD |
CY2012Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization and Description of Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Healthcare Trust of America, Inc., a Maryland corporation, was incorporated on April 20, 2006. We were initially capitalized on April 28, 2006 and consider that to be our date of inception. </font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are a fully integrated, self-administered and internally managed real estate investment trust, or REIT, primarily focused on acquiring, owning and operating high-quality medical office buildings that are predominantly located on or aligned with campuses of nationally or regionally recognized healthcare systems. We are one of the largest public REITs focused on medical office buildings in the United States based on gross leasable area, or GLA, and have strong industry relationships, a stable and diversified tenant mix and an extensive and active acquisition network. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments and to provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we target mid-sized acquisitions of high-quality medical office buildings in markets with dominant healthcare systems, attractive demographics and that complement our existing portfolio, actively manage our balance sheet to maintain flexibility with conservative leverage, and seek internal growth through proactive asset management, leasing and property management oversight. We have qualified to be taxed as a REIT for federal income tax purposes and we intend to continue to be taxed as a REIT. We conduct substantially all of our operations through Healthcare Trust of America Holdings, LP, or our operating partnership.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We invest primarily in high-quality medical office buildings in our target markets, and have acquired high-quality medical office buildings and other facilities that serve the healthcare industry with an aggregate purchase price of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,548,860,000</font><font style="font-family:inherit;font-size:10pt;"> through </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2012</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2012</font><font style="font-family:inherit;font-size:10pt;">, our portfolio consisted of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">245</font><font style="font-family:inherit;font-size:10pt;"> medical office buildings and 19 other facilities that serve the healthcare industry, as well as </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> portfolios of mortgage loans receivable secured by medical office buildings.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 20, 2006, we commenced a best efforts initial public offering, or our initial offering, in which we offered up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">200,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share in a primary offering and up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">21,052,632</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock pursuant to our distribution reinvestment plan, or the DRIP, at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share, aggregating up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,200,000,000</font><font style="font-family:inherit;font-size:10pt;">. On March 19, 2010, we commenced a best efforts follow-on public offering, or our follow-on offering, in which we offered up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">200,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share in a primary offering and up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">21,052,632</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock pursuant to the DRIP at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share, aggregating up to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,200,000,000</font><font style="font-family:inherit;font-size:10pt;">. We stopped offering shares in the follow-on offering on February 28, 2011. In aggregate, we received and accepted subscriptions in our initial and follow-on offerings for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">220,673,545</font><font style="font-family:inherit;font-size:10pt;"> shares of our common stock, or </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2,195,655,000</font><font style="font-family:inherit;font-size:10pt;">, excluding shares of our common stock issued under the DRIP. We continue to offer shares pursuant to the DRIP; however we may terminate the DRIP at any time. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our principal executive offices are located at 16435 N. Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254. Our telephone number is (480) 998-3478. For investor services, contact DST Systems, Inc. by telephone at (888) 801-0107.</font></div></div> | |
CY2012Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
160338000 | USD |
CY2011Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
181497000 | USD |
CY2012Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-220814000 | USD |
CY2011Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-28472000 | USD |
CY2011Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
25110000 | USD |
CY2012Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
26105000 | USD |
CY2011Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2150000 | USD |
CY2012Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-315000 | USD |
CY2011Q4 | us-gaap |
Notes And Loans Payable
NotesAndLoansPayable
|
639149000 | USD |
CY2012Q1 | us-gaap |
Notes And Loans Payable
NotesAndLoansPayable
|
636466000 | USD |
CY2011Q4 | us-gaap |
Notes Receivable Net
NotesReceivableNet
|
57459000 | USD |
CY2012Q1 | us-gaap |
Notes Receivable Net
NotesReceivableNet
|
57431000 | USD |
CY2011Q4 | us-gaap |
Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
|
11832000 | USD |
CY2012Q1 | us-gaap |
Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
|
12899000 | USD |
CY2011Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
11914000 | USD |
CY2012Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
10699000 | USD |
CY2011Q4 | us-gaap |
Other Assets
OtherAssets
|
56442000 | USD |
CY2012Q1 | us-gaap |
Other Assets
OtherAssets
|
64541000 | USD |
CY2012Q1 | us-gaap |
Other Liabilities
OtherLiabilities
|
23270000 | USD |
CY2011Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
19930000 | USD |
CY2011Q4 | us-gaap |
Other Restricted Assets
OtherRestrictedAssets
|
16718000 | USD |
CY2012Q1 | us-gaap |
Other Restricted Assets
OtherRestrictedAssets
|
17927000 | USD |
CY2011Q1 | us-gaap |
Payments For Previous Acquisition
PaymentsForPreviousAcquisition
|
0 | USD |
CY2012Q1 | us-gaap |
Payments For Previous Acquisition
PaymentsForPreviousAcquisition
|
328000 | USD |
CY2011Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
7916000 | USD |
CY2012Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
9916000 | USD |
CY2012Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
4777000 | USD |
CY2011Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
1555000 | USD |
CY2011Q1 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
19320000 | USD |
CY2012Q1 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
22246000 | USD |
CY2011Q1 | us-gaap |
Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
|
56000 | USD |
CY2012Q1 | us-gaap |
Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
|
30000 | USD |
CY2011Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
15002000 | USD |
CY2012Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | USD |
CY2012Q1 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
6695000 | USD |
CY2011Q1 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
2548000 | USD |
CY2011Q1 | us-gaap |
Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
|
29733000 | USD |
CY2012Q1 | us-gaap |
Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
|
213900000 | USD |
CY2011Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2012Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2012Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
200000000 | shares |
CY2011Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
200000000 | shares |
CY2012Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2011Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2012Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2011Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2011Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2012Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2011Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
210210000 | USD |
CY2012Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
CY2011Q1 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
125500000 | USD |
CY2012Q1 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
0 | USD |
CY2011Q1 | us-gaap |
Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
|
0 | USD |
CY2012Q1 | us-gaap |
Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
|
200000000 | USD |
CY2012Q1 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
182000000 | USD |
CY2011Q1 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
0 | USD |
CY2011Q1 | us-gaap |
Profit Loss
ProfitLoss
|
2190000 | USD |
CY2012Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-307000 | USD |
CY2012Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
225000 | USD |
CY2011Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
337000 | USD |
CY2011Q4 | us-gaap |
Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
|
1806471000 | USD |
CY2012Q1 | us-gaap |
Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
|
1973458000 | USD |
CY2011Q1 | us-gaap |
Real Estate Revenue Net
RealEstateRevenueNet
|
69243000 | USD |
CY2012Q1 | us-gaap |
Real Estate Revenue Net
RealEstateRevenueNet
|
69935000 | USD |
CY2011Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
|
3785000 | USD |
CY2012Q1 | us-gaap |
Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
|
3690000 | USD |
CY2011Q1 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
7000000 | USD |
CY2012Q1 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
182000000 | USD |
CY2011Q1 | us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
103496000 | USD |
CY2012Q1 | us-gaap |
Repayments Of Secured Debt
RepaymentsOfSecuredDebt
|
2563000 | USD |
CY2012Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-509066000 | USD |
CY2011Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-467249000 | USD |
CY2011Q1 | us-gaap |
Revenues
Revenues
|
70892000 | USD |
CY2012Q1 | us-gaap |
Revenues
Revenues
|
71243000 | USD |
CY2011Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
897000 | USD |
CY2012Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1002000 | USD |
CY2012Q1 | us-gaap |
Stock Issued1
StockIssued1
|
19148000 | USD |
CY2011Q1 | us-gaap |
Stock Issued1
StockIssued1
|
17651000 | USD |
CY2011Q1 | us-gaap |
Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
|
17651000 | USD |
CY2012Q1 | us-gaap |
Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
|
19148000 | USD |
CY2011Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
210210000 | USD |
CY2011Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | USD |
CY2012Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | USD |
CY2012Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
9916000 | USD |
CY2011Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
7916000 | USD |
CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1567340000 | USD |
CY2012Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1535757000 | USD |
CY2011Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1656705000 | USD |
CY2010Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1487246000 | USD |
CY2012Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-508000 | USD |
CY2011Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
504000 | USD |
CY2012Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
228881454 | shares |
CY2011Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
214996502 | shares |
CY2012Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
228881454 | shares |
CY2011Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
214797450 | shares |
CY2012Q1 | hta |
Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
|
12388000 | USD |
CY2011Q4 | hta |
Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
|
12658000 | USD |
CY2012Q1 | hta |
Depreciation And Amortization Including Deferred Financing Costs Above Below Market Leases Debt Discount Leasehold Interests Deferred Rent Receivable Note Receivable Closing Costs And Discount And Lease Inducements
DepreciationAndAmortizationIncludingDeferredFinancingCostsAboveBelowMarketLeasesDebtDiscountLeaseholdInterestsDeferredRentReceivableNoteReceivableClosingCostsAndDiscountAndLeaseInducements
|
26716000 | USD |
CY2011Q1 | hta |
Depreciation And Amortization Including Deferred Financing Costs Above Below Market Leases Debt Discount Leasehold Interests Deferred Rent Receivable Note Receivable Closing Costs And Discount And Lease Inducements
DepreciationAndAmortizationIncludingDeferredFinancingCostsAboveBelowMarketLeasesDebtDiscountLeaseholdInterestsDeferredRentReceivableNoteReceivableClosingCostsAndDiscountAndLeaseInducements
|
23998000 | USD |
CY2012Q1 | hta |
Distributions
Distributions
|
41502000 | USD |
CY2011Q1 | hta |
Distributions
Distributions
|
38531000 | USD |
CY2012Q1 | hta |
Distributions Declared But Not Paid Including Stock Issued Under Drip
DistributionsDeclaredButNotPaidIncludingStockIssuedUnderDrip
|
13229000 | USD |
CY2011Q1 | hta |
Distributions Declared But Not Paid Including Stock Issued Under Drip
DistributionsDeclaredButNotPaidIncludingStockIssuedUnderDrip
|
13839000 | USD |
CY2011Q1 | hta |
Real Estate Deposits Used
RealEstateDepositsUsed
|
3000000 | USD |
CY2011Q1 | hta |
Restricted Cash And Escrow Deposits
RestrictedCashAndEscrowDeposits
|
-1309000 | USD |
CY2012Q1 | hta |
Restricted Cash And Escrow Deposits
RestrictedCashAndEscrowDeposits
|
1209000 | USD |
CY2012Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2012Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2012Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2012Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2012 | |
CY2012Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2012-03-31 | |
CY2012Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2012Q1 | hta |
Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities
IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities
|
3098000 | USD |
CY2011Q1 | hta |
Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities
IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities
|
219000 | USD |
CY2012Q1 | hta |
Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments
InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments
|
800000 | USD |
CY2011Q1 | hta |
Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments
InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments
|
-144000 | USD |
CY2012Q1 | hta |
Interest Expense Related To Mortgage Loans Payable And Credit Facility
InterestExpenseRelatedToMortgageLoansPayableAndCreditFacility
|
10233000 | USD |
CY2011Q1 | hta |
Interest Expense Related To Mortgage Loans Payable And Credit Facility
InterestExpenseRelatedToMortgageLoansPayableAndCreditFacility
|
9986000 | USD |
CY2012Q1 | hta |
Interest Income From Mortgage Notes Receivable And Other Income
InterestIncomeFromMortgageNotesReceivableAndOtherIncome
|
1308000 | USD |
CY2011Q1 | hta |
Interest Income From Mortgage Notes Receivable And Other Income
InterestIncomeFromMortgageNotesReceivableAndOtherIncome
|
1649000 | USD |
CY2012Q1 | hta |
Proceeds From Security Deposits
ProceedsFromSecurityDeposits
|
198000 | USD |
CY2011Q1 | hta |
Proceeds From Security Deposits
ProceedsFromSecurityDeposits
|
132000 | USD |
CY2011Q1 | hta |
Real Estate Deposits Paid
RealEstateDepositsPaid
|
500000 | USD |
CY2012Q1 | hta |
Real Estate Deposits Paid
RealEstateDepositsPaid
|
2810000 | USD |
CY2012Q1 | hta |
Real Estate Deposits Used
RealEstateDepositsUsed
|
3800000 | USD |
CY2012Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001360604 | |
CY2012Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
230597292 | shares |
CY2012Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2012Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2011Q2 | dei |
Entity Public Float
EntityPublicFloat
|
1624601000 | USD |
CY2012Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
HEALTHCARE TRUST OF AMERICA, INC. | |
CY2012Q1 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2012Q1 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No |